D70.1 AGRANULOCYTOSIS SECONDARY TO CANCER CHEMOTHERAPY

Code Information

  • Diagnosis Code: D70.1
  • Short Description: Agranulocytosis secondary to cancer chemotherapy
  • Long Description: Agranulocytosis secondary to cancer chemotherapy
  • Code Version: 2025 ICD-10-CM

The code D70.1 is VALID for claim submission

Code Classification

Synonyms

  • Agranulocytosis
  • Agranulocytosis due to and following administration of antineoplastic agent
  • Neutropenia due to and following chemotherapy

Diagnostic Related Group(s)

The code D70.1 is grouped in the following Diagnostic Related Group(s) MS-DRG V42.0

  1. Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders With Mcc (808)
  2. Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders With Cc (809)
  3. Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders Without Cc/mcc (810)

References to Index of Diseases and Injuries

The code D70.1 has the following ICD-10-CM references to the Index of Diseases and Injuries

  • Code Also:
    • underlying neoplasm

Crosswalk Information

ICD-10 Code ICD-9 Code ICD-9 Description
D70.1 Right Arrow 288.03 Drug induced neutropenia
This ICD-10 to ICD-9 data is based on the 2018 General Equivalency Mapping (GEM) files published by the Centers for Medicare & Medicaid Services (CMS) for informational purposes only. The data is not an ICD-10 conversion tool and doesn’t guarantee clinical accuracy.

Similar Codes

ICD-10 Code ICD-10 Description
D70 Neutropenia
D70.0 Congenital agranulocytosis
D70.2 Other drug-induced agranulocytosis
D70.3 Neutropenia due to infection
D70.4 Cyclic neutropenia
D70.8 Other neutropenia
D70.9 Neutropenia, unspecified
This page was last updated on: 10/1/2024
Previous Code
Next Code